Atlas Trials

Effect of Paricalcitol on Markers of Inflammation in Hemodialysis Patients

Clinical trial NCT00294866 · COMPLETED

Trial details

NCT number
NCT00294866
Sponsor
Fresenius Medical Care North America
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Kidney Failure
Start date
2006-03-01
Primary completion
2008-01-01
Enrollment
64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.